Common Stock, Shares, Outstanding of BioXcel Therapeutics, Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
BioXcel Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • BioXcel Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 19,996,000, a 53% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

BioXcel Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 19,996,000 -22,466,000 -53% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 6,620,000 -33,763,000 -84% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 5,468,000 -28,164,000 -84% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 3,102,000 +1,231,000 +66% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 42,462,000 +13,189,000 +45% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 40,383,000 +11,116,000 +38% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 33,632,000 +4,532,000 +16% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 1,871,000 -26,276,000 -93% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 29,273,000 +1,250,000 +4.5% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 29,267,000 +1,249,000 +4.5% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 29,100,000 +1,120,000 +4% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 28,147,000 +167,000 +0.6% 31 Dec 2022 10-K 22 Mar 2024 2023 FY
Q3 2022 28,023,000 +43,000 +0.15% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 28,018,000 +49,000 +0.18% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 27,980,000 +3,349,000 +14% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 27,980,000 +3,563,000 +15% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 27,980,000 +3,625,118 +15% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 27,969,000 +7,616,087 +37% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 24,631,000 +4,448,618 +22% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 24,417,000 +6,330,000 +35% 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q3 2020 24,354,882 +6,319,857 +35% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 20,352,913 +4,665,367 +30% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 20,182,382 +4,516,580 +29% 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 18,087,000 +2,423,779 +15% 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 18,035,025 +2,389,480 +15% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 15,687,546 +42,001 +0.27% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 15,665,802 +20,257 +0.13% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 15,663,221 +5,755,673 +58% 31 Dec 2018 10-K 09 Mar 2020 2019 FY
Q3 2018 15,645,545 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 15,645,545 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 15,645,545 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 9,907,548 31 Dec 2017 10-K 12 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.